STAT+: FDA approves new breast cancer drug, providing new option for some patients, boost for Roche

The Food and Drug Administration on Monday approved a new breast cancer drug from Roche, teeing up the launch of a medicine that the Swiss company has said could become its top-selling product ever. The approval of Wilserdly, also known as…
ImpactNotable
Published3 h ago (Mon, 16 Nov 2026 20:56:47 GMT)
AuthorAndrew Joseph
MoreLess
Impact score36/100
RatingRule-based estimate: event keywords (+4); trust 8/10.
RegionsGlobal
Retrievedvia rss
ClassifiedMon, 16 Nov 2026 21:00:26 GMT by heuristic